HealthSouth increase authorization to repurchase stock up to $350M HealthSouth Corporation announced its board of directors approved an increase in the company's existing common stock repurchase authorization from $125M to $350M. The Company intends to pursue a tender offer for its common stock for up to the full amount of this authorization, the timing and parameters of which will be dictated by market conditions. Any such tender offer would be funded with a combination of cash on hand and availability under the Company's $600 million revolving credit facility. Even if successful at the full amount authorized, any such tender offer would result in a modest impact on the Company's leverage ratio, with the resulting ratio remaining within the Company's target range. The Company believes the contemplated tender offer is consistent with its strategy of deploying financial resources towards long-term, shareholder value-creating opportunities.
BofA/Merrill healthcare high yield analyst has analyst/industry conference call Healthcare High Yield Analyst Bland provides an update on the current state of the bond markets and the ability of healthcare providers to utilize debt financing on an Analyst/Industry conference call to be held on March 24 at 10 am.